<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Dosing of penicillin, antistaphylococcal penicillins, and broad-spectrum penicillins in adult patients with dose adjustments for kidney impairment</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Dosing of penicillin, antistaphylococcal penicillins, and broad-spectrum penicillins in adult patients with dose adjustments for kidney impairment</h1>
<div class="graphic"><div class="figure"><div class="ttl">Dosing of penicillin, antistaphylococcal penicillins, and broad-spectrum penicillins in adult patients with dose adjustments for kidney impairment</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">CrCl (mL/minute)</td> <td class="subtitle1">Usual adult dose</td> <td class="subtitle1">Frequency</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Penicillin</td> </tr> <tr> <td class="indent1" rowspan="2">Penicillin V potassium (oral)</td> <td>No adjustment necessary<sup>[1]</sup>; excretion may be delayed in severe kidney impairment</td> <td>250 to 500 mg orally</td> <td>Every 6 to 12 hours</td> </tr> <tr> <td>iHD*<sup>[1]</sup></td> <td>250 to 500 mg orally</td> <td>Every 6 to 12 hours*</td> </tr> <tr> <td class="indent1" rowspan="5">Penicillin G (IV)<sup>¶</sup></td> <td>≥15 (non-uremic)</td> <td>2 to 5 million units IV</td> <td>Every 4 to 6 hours (or total daily dose as a 24-hour continuous infusion)</td> </tr> <tr> <td>10 to &lt;15 (uremic)</td> <td> <p>Loading dose: 2 to 5 million units IV once</p> Maintenance dose: 1 to 2.5 million units IV</td> <td>Every 4 to 5 hours (maintenance dose)</td> </tr> <tr> <td>&lt;10</td> <td> <p>Loading dose: 2 to 5 million units IV once</p> Maintenance dose: 1 to 2.5 million units IV</td> <td>Every 8 to 10 hours (maintenance dose)</td> </tr> <tr> <td>iHD*<sup>[1]</sup></td> <td> <p>Loading dose: 2 to 5 million units IV once</p> Maintenance dose: 0.5 to 2.5 million units IV</td> <td>Every 4 to 6 hours (maintenance dose)*</td> </tr> <tr> <td>CVVHD (1 to 2 L/hour)<sup>[2]</sup></td> <td> <p>Loading dose: 4 million units IV once</p> Maintenance dose: 2 to 3 million units IV</td> <td>Every 4 to 6 hours (maintenance dose)</td> </tr> <tr> <td class="indent1">Penicillin G procaine<sup>Δ</sup> (intermediate-acting IM suspension)</td> <td>No specific adjustment available; excretion may be delayed in severe kidney impairment</td> <td>600,000 to 2.4 million units IM</td> <td>Every 24 hours (or divided every 12 hours)</td> </tr> <tr> <td class="indent1">Penicillin G benzathine and penicillin G procaine<sup>Δ</sup> (mixture of intermediate- and long-acting IM suspension)</td> <td>No specific adjustment available; excretion may be delayed in severe kidney impairment</td> <td>1.2 to 2.4 million units IM</td> <td>Single dose or repeated after 2 to 3 days</td> </tr> <tr> <td class="indent1">Penicillin G benzathine<sup>Δ</sup> (long-acting intramuscular suspension)</td> <td>No specific adjustment available; excretion may be delayed in severe kidney impairment</td> <td>1.2 to 2.4 million units IM</td> <td>Single dose or repeated weekly</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Antistaphylococcal penicillins</td> </tr> <tr> <td class="indent1">Cloxacillin (oral)<sup>◊</sup></td> <td>No adjustment necessary</td> <td>250 to 500 mg<sup>◊</sup></td> <td>Every 6 hours</td> </tr> <tr> <td class="indent1">Cloxacillin (IV)<sup>◊</sup></td> <td>No adjustment necessary</td> <td>2 g IV<sup>◊</sup></td> <td>Every 4 to 6 hours</td> </tr> <tr> <td class="indent1">Dicloxacillin (oral)</td> <td>No adjustment necessary</td> <td>250 to 500 mg orally</td> <td>Oral: Every 6 hours</td> </tr> <tr> <td class="indent1">Dicloxacillin (IV)<sup>◊</sup></td> <td>No adjustment necessary</td> <td>1 to 2 g IV<sup>◊</sup></td> <td>Every 4 to 6 hours</td> </tr> <tr> <td class="indent1">Nafcillin (IV)</td> <td>No adjustment necessary</td> <td>1 to 2 g IV</td> <td>Every 4 to 6 hours (or total daily dose as a 24-hour continuous infusion)</td> </tr> <tr> <td class="indent1">Oxacillin (IV)</td> <td>No adjustment necessary; caution in end stage kidney disease<sup>§</sup></td> <td>1 to 2 g IV</td> <td>Every 4 hours</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Second-generation penicillins (aminopenicillins)</td> </tr> <tr> <td class="indent1" rowspan="5">Amoxicillin (oral, immediate-release)</td> <td>&gt;30</td> <td>500 mg to 1 g orally</td> <td>Every 8 to 12 hours</td> </tr> <tr> <td>10 to 30</td> <td>250 mg to 1 g orally</td> <td>Every 12 hours</td> </tr> <tr> <td>&lt;10</td> <td>250 to 500 mg orally</td> <td>Every 12 to 24 hours</td> </tr> <tr> <td>iHD*</td> <td>250 to 500 mg orally</td> <td>Every 12 to 24 hours*</td> </tr> <tr> <td>PD</td> <td>250 to 500 mg orally</td> <td>Every 12 hours</td> </tr> <tr> <td class="indent1" rowspan="7">Ampicillin (IV)</td> <td>≥50</td> <td>1 to 2 g IV</td> <td>Every 4 to 6 hours</td> </tr> <tr> <td>30 to &lt;50</td> <td>1 to 2 g IV</td> <td>Every 6 to 8 hours</td> </tr> <tr> <td>15 to &lt;30</td> <td>1 to 2 g IV</td> <td>Every 8 to 12 hours</td> </tr> <tr> <td>&lt;15</td> <td>1 to 2 g IV</td> <td>Every 12 to 24 hours</td> </tr> <tr> <td>iHD*</td> <td>1 to 2 g IV</td> <td>Every 12 to 24 hours*</td> </tr> <tr> <td>PD</td> <td>1 to 2 g IV</td> <td>Every 12 to 24 hours</td> </tr> <tr> <td>CVVHD<sup>[2,3]</sup></td> <td>1 to 2 g IV</td> <td>Every 6 to 12 hours</td> </tr> <tr> <td class="indent1" rowspan="5">Ampicillin (oral)<sup>[2]</sup></td> <td>≥50</td> <td>250 to 500 mg orally</td> <td>Every 6 hours</td> </tr> <tr> <td>10 to &lt;50</td> <td>250 to 500 mg orally</td> <td>Every 6 to 12 hours</td> </tr> <tr> <td>&lt;10</td> <td>250 to 500 mg orally</td> <td>Every 12 to 16 hours</td> </tr> <tr> <td>iHD*</td> <td>250 to 500 mg orally</td> <td>Every 12 to 24 hours; supplemental dose after each dialysis session*</td> </tr> <tr> <td>PD</td> <td>250 mg orally</td> <td>Every 12 hours</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Other broad-spectrum penicillin</td> </tr> <tr> <td class="indent1" rowspan="6">Piperacillin (IV)<sup>◊¥</sup></td> <td>≥40</td> <td>3 to 4 g IV</td> <td>Every 4 to 6 hours</td> </tr> <tr> <td>20 to 40</td> <td>4 g IV</td> <td>Every 8 hours</td> </tr> <tr> <td>&lt;20</td> <td>4 g IV</td> <td>Every 12 hours</td> </tr> <tr> <td>iHD*</td> <td>2 g IV</td> <td>Every 8 hours; 1 g supplemental dose after each dialysis session*</td> </tr> <tr> <td>PD</td> <td>4 g IV</td> <td>Every 12 hours</td> </tr> <tr> <td>CRRT<sup>[1]</sup></td> <td>4 g IV</td> <td>Every 8 hours</td> </tr> </tbody></table></div><div class="graphic_lgnd"><ul>
<li>This table lists doses of penicillin antibiotics, with suggested dosing adjustments for kidney impairment. The first dose listed for each agent represents the suggested dose range for normal kidney function. For specific dosing recommendations, refer to related disease treatment topics(s) and Lexicomp drug monograph.</li>
<li>Kidney function is evaluated based on estimated CrCl using the Cockcroft-Gault equation. A calculator for estimating CrCl based on the Cockcroft-Gault equation is available in UpToDate. Combinations of penicillins with beta-lactamase inhibitors (eg, amoxicillin-clavulanate, piperacillin-tazobactam) are reviewed separately; refer to separate topic review and table of combination beta-lactamase inhibitors, carbapenems, and monobactams.</li>
</ul></div><div class="graphic_footnotes"><p>CrCl: creatinine clearance; CVVHD: continuous veno-venous hemodialysis; CRRT: continuous renal replacement therapy; iHD: intermittent hemodialysis; PD: peritoneal dialysis.</p>
<p>* Based on three times weekly dialysis sessions of 3 to 4 hours each; on dialysis days administer dose after dialysis. A loading dose or supplemental dose following dialysis may be warranted for some antibiotics depending on clinical scenario; refer to Lexicomp monograph for detail.</p>
<p>¶ Alternative suggested adjustment for kidney impairment: GFR &gt;50 mL/min: No adjustment; GFR 10 to 50 mL/min: 75% of indication-specific dose; GFR &lt;10 mL/min: 20 to 50% of indication-specific dose.<sup>[1]</sup></p>
<p>Δ Suspension formulations of penicillin are for intramuscular use only and must <strong>not</strong> be administered intravenously.</p>
<p>◊ Not available in the United States but may be available elsewhere.</p>
<p>§ For those with CrCl &lt;10 mL/minute, on iHD, or on PD, monitor for signs of accumulation (eg, neurotoxicity) or consider alternatives.</p>
¥ Dosing for severe infections; lower and/or less frequent dosing recommended in milder infections. For dosing of the combination piperacillin-tazobactam product available in the United States, refer to separate table in UpToDate and Lexicomp monograph.</div><div class="graphic_reference">References:
<ol>
<li>Aronoff GR, Bennett WM, Berns JS, et al. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children, 5th ed, American College of Physicians 2007.</li>
<li>Golightly LK, Teitelbaum I, Kiser TH, et al, eds. Renal Pharmacotherapy: Dosage Adjustment of Medications Eliminated by the Kidneys, Springer 2013.</li>
<li>Heintz BH, Matzke GR, Dager WE. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 2009; 29:562.</li>
</ol>
<p class="extra_spacing_top">Data from: Lexicomp Online. Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.</p></div><div id="graphicVersion">Graphic 142581 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
